Chemoembolic hepatopulmonary shunt reduction to allow safe yttrium-90 radioembolization lobectomy of hepatocellular carcinoma

CardioVascular and Interventional Radiology

Volumn 35, Issue 6, 2012, Pages 1505-1511

  Gaba, Ron C ^a   Vanmiddlesworth, Kyle A ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

Chemoembolization; Hepatocellular carcinoma; Pulmonary shunt; Radioembolization

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; DOXORUBICIN; IODINATED POPPYSEED OIL; MACROSALB TC 99M; MITOMYCIN; OCTREOTIDE; PANTOPRAZOLE; PROPRANOLOL; SERUM ALBUMIN TC 99M; YTTRIUM 90; CONTRAST MEDIUM; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; YTTRIUM;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGED; ANGIOGRAPHY; ARTERY CATHETER; ARTICLE; CANCER SURVIVAL; CASE REPORT; CENTRAL VENOUS CATHETER; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DRUG SAFETY; ECHOGRAPHY; EMBOLIC PARTICLE; ERYTHROCYTE TRANSFUSION; FATIGUE; HEMOSTASIS; HEPATITIS C; HUMAN; LIVER ARTERIOGRAPHY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER LOBECTOMY; LOSS OF APPETITE; MALE; MICROCATHETER; PRIORITY JOURNAL; PULMONARY SHUNT; RADIATION DOSE; TREATMENT RESPONSE; TUMOR INVASION; VARICOSIS; VASCULAR TUMOR; HEPATOPULMONARY SYNDROME; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PORTAL VEIN; RADIOGRAPHY; SCINTISCANNING;

AGED; ANGIOGRAPHY; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; HEPATOPULMONARY SYNDROME; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PORTAL VEIN; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TOMOGRAPHY, X-RAY COMPUTED; YTTRIUM RADIOISOTOPES;

EID: 84878229427     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-012-0371-7     Document Type: Article

References (20)

1. Kennedy AS, Salem R (2010) Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies. Cancer J 16:163-175
2. Requarth J (2011) Image-guided palliative care procedures. Surg Clin North Am 91:367-402
3. Kulik LM, Atassi B, van Holsbeeck L et al (2006) Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 94:572-586
4. Lewandowski RJ, Kulik LM, Riaz A et al (2009) A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant 9:1920-1928
5. 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol 17:1251-1278
6. Fleming CJ, Andrews JC, Wiseman GA, Gansen DN, Roberts LR (2009) Hepatic vein tumor thrombus as a risk factor for excessive pulmonary deposition of microspheres during TheraSphere therapy for unresectable hepatocellular carcinoma. J Vasc Interv Radiol 20:1460-1463
7. Furuse J, Iwasaki M, Yoshino M et al (1997) Hepatocellular carcinoma with portal vein tumor thrombus: embolization of arterioportal shunts. Radiology 204:787-790
8. Rose SC, Hoh CK (2009) Hepatopulmonary shunt reduction using chemoembolization to permit yttrium-90 radioembolization. J Vasc Interv Radiol 20:849-851
9. Leung TW, Lau WY, Ho SK et al (1995) Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 33:919-924
10. Bester L, Salem R (2007) Reduction of arteriohepatovenous shunting by temporary balloon occlusion in patients undergoing radioembolization. J Vasc Interv Radiol 18:1310-1314
11. Ngan H, Peh WC (1997) Arteriovenous shunting in hepatocellular carcinoma: its prevalence and clinical significance. Clin Radiol 52:36-40
12. Salem R, Lewandowski R, Roberts C et al (2004) Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 15:335-345
13. Wu JJ, Chao M, Zhang GQ, Li B, Dong F (2009) Pulmonary and cerebral lipiodol embolism after transcatheter arterial chemoembolization in hepatocellular carcinoma. World J Gastroenterol 15:633-635
14. Zhao H, Wang HQ, Fan QQ, Chen XX, Lou JY (2008) Rare pulmonary and cerebral complications after transarterial chemoembolization for hepatocellular carcinoma: a case report. World J Gastroenterol 14:6425-6427
15. Wiggins E, Ibrahim SM, Lewandowski RJ, Sato KT, Omary RA, Salem R (2008) Effect of chemotherapy on hepatic vasculature in patients undergoing Y-90 radioembolization for metastatic disease. J Vasc Interv Radiol 19:S48-S49
16. Gaba RC, Brodsky TR, Knuttinen MG, Omene BO, Owens CA, Bui JT (2012) Hepatic arterial changes following iodized oil chemoembolization of hepatocellular carcinoma: incidence and therapeutic consequence. Artery Res 6:21-27
17. Gaba RC, Lewandowski RJ, Kulik LM et al (2009) Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization. Ann Surg Oncol 16:1587-1596
18. Gaba RC, Carroll JJ, Bui JT, Carrillo TC, Knuttinen MG, Owens CA (2011) Chemoembolic lobectomy: imaging findings of hepatic lobar volume reduction after transcatheter arterial chemoembolization. Diagn Interv Radiol 17:177-180
19. Salem R, Lewandowski RJ, Mulcahy MF et al (2010) Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 138:52-64
20. Lewandowski RJ, Mulcahy MF, Kulik LM et al (2010) Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort. Radiology 255:955-965